Sibutramine and blood pressure: a therapeutic dilemma.

about

Sibutramine and blood pressure: a therapeutic dilemma.

Item

http://www.wikidata.org/entity/Q43882698

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Sibutramine and blood pressure: a therapeutic dilemma.

@en

Sibutramine and blood pressure: a therapeutic dilemma.

@nl

type

Item

label

Sibutramine and blood pressure: a therapeutic dilemma.

@en

Sibutramine and blood pressure: a therapeutic dilemma.

@nl

prefLabel

Sibutramine and blood pressure: a therapeutic dilemma.

@en

Sibutramine and blood pressure: a therapeutic dilemma.

@nl

P1476

Sibutramine and blood pressure: a therapeutic dilemma.

@en

P2860

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Obesity and hypertension: epidemiological and clinical issues.

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial.

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial.

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.

P2888

sj.jhh.1001297

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.JHH.1001297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

George A. Bray

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11521191

http://www.w3.org/2001/XMLSchema#string

P6179

1044967099

http://www.w3.org/2001/XMLSchema#string

P698

11840223

http://www.w3.org/2001/XMLSchema#string